UPMC Hillman Cancer Center at ASH 2026
Dec 12–15, 2026 New Orleans, LA ~30k attendees Website
UPMC Hillman Cancer Center brings 2 presentations to ASH 2026 in New Orleans, and exhibits at Booth 200. Its program centres on acute myeloid leukemia drug development and early career support for faculty and trainees. It covers a phase 1 study of an oral bcl-2 inhibitor and lessons from developing a DHODH inhibitor in an academic setting.
| Organization | ASH 2026 Attendance |
|---|---|
UPMC Hillman Cancer Center Pittsburgh, PA | |
NCI-designated comprehensive cancer center of UPMC and the University of Pittsburgh. | Booth Exhibiting at Booth 200 Sat, Dec 1211:00am–5:00pmSun, Dec 1310:00am–5:00pmMon, Dec 1410:00am–2:00pm Session Fri Dec 11 1:35pm–3:55pm Talk Fri Dec 11 5:20pm–5:55pm Poster Sat Dec 12 5:30pm–7:30pm Session Sun Dec 13 9:30am–11:00am Early Faculty Career Development Session Surviving early academic careers in hematology, from non-academic career paths and diversified funding to imposter syndrome, saying no, and negotiating. |
Find decision makers at UPMC Hillman Cancer Center
Tell us what you sell and we’ll find the people at UPMC Hillman Cancer Center most likely to buy it.
- Who to contact
- Their contact info
- What to say
- Free, no sign-up
Not affiliated with or endorsed by the American Society of Hematology (ASH). Submit a correction